🔎 Trials Near Me

Hem › Lungsjukdomar › Tennessee

Kliniska studier för Lungsjukdomar i Tennessee

15 studier för Lungsjukdomar söker deltagare vid platser i Tennessee.

Städer i Tennessee

Officiell studietext (engelska)

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

  • SCRI Oncology Partners, Nashville
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 30 sep. 2026 · NCT06765109

A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

  • WR-Clinsearch, LLC, Chattanooga
RekryterarFas 3
Ålder 12 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT06679140

Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC

  • University of Tennessee Medical Center, Knoxville
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT07489066

A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised

  • West Tennessee Research Institute, Jackson
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT07013474

American Lung Association (ALA) Lung Health Cohort

  • Vanderbilt University Medical Center, Nashville
RekryterarObservationsstudieFriska volontärer välkomna
Ålder 25 till 35 · Alla kön · Uppdaterad 23 sep. 2026 · NCT04543461

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

  • Sarah Cannon Research Institue, Nashville
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 22 sep. 2026 · NCT06128551

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma

  • Premier Research Center, LLC, Hendersonville
RekryterarFas 2
Ålder 18 till 70 · Alla kön · Uppdaterad 22 sep. 2026 · NCT06977581

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  • Tennessee Oncology Chattanooga, Chattanooga
  • University of Tennessee Medical Center, Knoxville
  • Baptist Memorial Hospital-Memphis, Memphis
  • och 2 fler
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 8 sep. 2026 · NCT06119581

Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD

  • Vanderbilt University Medical Center, Nashville
RekryterarFas 2
Ålder 40 och äldre · Alla kön · Uppdaterad 4 sep. 2026 · NCT07059091

Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)

  • Clinical Trials Center of Middle Tennesee LLC, Franklin
RekryterarFas 3
Ålder 40 och äldre · Alla kön · Uppdaterad 3 sep. 2026 · NCT07284602

A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.

  • SCRI Oncology Partners, Nashville
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 1 sep. 2026 · NCT05967689

Cooperative Assessment of Late Effects for SCD Curative Therapies

  • Vanderbilt University Medical Center, Nashville
RekryterarObservationsstudie
Ålder 4 till 65 · Alla kön · Uppdaterad 27 juli 2026 · NCT05153967

Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer

  • University of Tennessee Medical Center, Knoxville
  • Baptist Cancer Center, Memphis
RekryterarFas 2
Ålder 18 till 70 · Alla kön · Uppdaterad 26 juni 2026 · NCT04614103

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

  • Baptist Memorial Hospital Baptist Cancer Center, Memphis
RekryterarFas 1/2
Ålder 12 och äldre · Alla kön · Uppdaterad 27 maj 2026 · NCT03093116

A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)

  • Tristar Bone Marrow Transplant, Nashville
  • Vanderbilt-Ingram Cancer Center, Nashville
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 15 dec. 2025 · NCT06619561

Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.